Guy Van den Mooter

2.6k total citations
41 papers, 2.2k citations indexed

About

Guy Van den Mooter is a scholar working on Materials Chemistry, Pharmaceutical Science and Biomaterials. According to data from OpenAlex, Guy Van den Mooter has authored 41 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Materials Chemistry, 14 papers in Pharmaceutical Science and 9 papers in Biomaterials. Recurrent topics in Guy Van den Mooter's work include Mesoporous Materials and Catalysis (19 papers), Drug Solubulity and Delivery Systems (13 papers) and Advanced Drug Delivery Systems (7 papers). Guy Van den Mooter is often cited by papers focused on Mesoporous Materials and Catalysis (19 papers), Drug Solubulity and Delivery Systems (13 papers) and Advanced Drug Delivery Systems (7 papers). Guy Van den Mooter collaborates with scholars based in Belgium, Serbia and France. Guy Van den Mooter's co-authors include Patrick Augustijns, Johan A. Martens, Randy Mellaerts, Jan Van Humbeeck, Michiel Van Speybroeck, Pieter Annaert, Caroline Aerts, Raf Mols, Thao Do Thi and Jasper Jammaer and has published in prestigious journals such as Gastroenterology, Langmuir and Chemical Communications.

In The Last Decade

Guy Van den Mooter

39 papers receiving 2.1k citations

Peers

Countries citing papers authored by Guy Van den Mooter

Since Specialization

Citations

This map shows the geographic impact of Guy Van den Mooter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guy Van den Mooter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guy Van den Mooter more than expected).

Fields of papers citing papers by Guy Van den Mooter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guy Van den Mooter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guy Van den Mooter. The network helps show where Guy Van den Mooter may publish in the future.

Co-authorship network of co-authors of Guy Van den Mooter

This figure shows the co-authorship network connecting the top 25 collaborators of Guy Van den Mooter. A scholar is included among the top collaborators of Guy Van den Mooter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guy Van den Mooter. Guy Van den Mooter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Investigation of process/formulation parameters on Inulin-Eudragit RS film properties: correlation between microstructure and film permeability 2025 ·International Journal of Pharmaceutics ·(unknown), (unknown), Pieter Vanden Berghe, Guy Van den Mooter	1
2	Ordered mesoporous silica to enhance the bioavailability of poorly water-soluble drugs: Proof of concept in man 2016 ·European Journal of Pharmaceutics and Biopharmaceutics ·(unknown), Laurent Schueller, Jan Rosier, (unknown), (unknown), Loes Verheyden, (unknown), Michiel Van Speybroeck, (unknown), Johan A. Martens, Guy Van den Mooter, Françoise Frérart, (unknown), M. De Gieter, Branko Bugarski, Filip Kiekens	89
3	Risk assessment of premature drug release during wet granulation of ordered mesoporous silica loaded with poorly soluble compounds itraconazole, fenofibrate, naproxen, and ibuprofen 2012 ·European Journal of Pharmaceutics and Biopharmaceutics ·(unknown), (unknown), Johan A. Martens, Guy Van den Mooter	25
4	Use of Ordered Mesoporous Silica to Enhance the Oral Bioavailability of Ezetimibe in Dogs 2011 ·Journal of Pharmaceutical Sciences ·Filip Kiekens, (unknown), Loes Verheyden, (unknown), Johan A. Martens, Guy Van den Mooter	33
5	Potential of amorphous microporous silica for ibuprofen controlled release 2010 ·International Journal of Pharmaceutics ·Caroline Aerts, (unknown), Anouschka Depla, Lana R. A. Follens, Ludo Froyen, J. Van Humbeeck, Patrick Augustijns, Guy Van den Mooter, Randy Mellaerts, Johan A. Martens	37
6	Molecular organization of hydrophobic molecules and co-adsorbed water in SBA-15 ordered mesoporous silica material 2010 ·Physical Chemistry Chemical Physics ·Randy Mellaerts, Maarten B. J. Roeffaers, Kristof Houthoofd, Michiel Van Speybroeck, Gert De Cremer, Jasper Jammaer, Guy Van den Mooter, Patrick Augustijns, Johan Hofkens, Johan A. Martens	42
7	Combined use of ordered mesoporous silica and precipitation inhibitors for improved oral absorption of the poorly soluble weak base itraconazole 2010 ·European Journal of Pharmaceutics and Biopharmaceutics ·Michiel Van Speybroeck, Raf Mols, Randy Mellaerts, Thao Do Thi, Johan A. Martens, Jan Van Humbeeck, Pieter Annaert, Guy Van den Mooter, Patrick Augustijns	106
8	Aging behavior of pharmaceutical formulations of itraconazole on SBA-15 ordered mesoporous silica carrier material 2009 ·Microporous and Mesoporous Materials ·Randy Mellaerts, Kristof Houthoofd, Ken Elen, Hong Chen, Michiel Van Speybroeck, Jan Van Humbeeck, Patrick Augustijns, J. Mullens, Guy Van den Mooter, Johan A. Martens	78
9	Solid State Characterization and Crystal Structure from X-ray Powder Diffraction of Two Polymorphic Forms of Ranitidine Base 2008 ·Journal of Pharmaceutical Sciences ·Héctor Novoa de Armas, Oswald M. Peeters, N. M. Blaton, Elke Van Gyseghem, Johan A. Martens, (unknown), Guy Van den Mooter	18
10	Ordered Mesoporous Silica Material SBA-15: A Broad-Spectrum Formulation Platform for Poorly Soluble Drugs 2008 ·Journal of Pharmaceutical Sciences ·Michiel Van Speybroeck, Valéry Barillaro, Thao Do Thi, Randy Mellaerts, Johan A. Martens, Jan Van Humbeeck, Jan Vermant, Pieter Annaert, Guy Van den Mooter, Patrick Augustijns	236
11	Increasing the oral bioavailability of the poorly water soluble drug itraconazole with ordered mesoporous silica 2007 ·European Journal of Pharmaceutics and Biopharmaceutics ·Randy Mellaerts, Raf Mols, Jasper Jammaer, Caroline Aerts, Pieter Annaert, Jan Van Humbeeck, Guy Van den Mooter, Patrick Augustijns, Johan A. Martens	199
12	Enhanced release of itraconazole from ordered mesoporous SBA-15 silica materials 2007 ·Chemical Communications ·Randy Mellaerts, Caroline Aerts, Jan Van Humbeeck, Patrick Augustijns, Guy Van den Mooter, Johan A. Martens	201
13	Intestinal Absorption Enhancement of the Ester Prodrug Tenofovir Disoproxil Fumarate through Modulation of the Biochemical Barrier by Defined Ester Mixtures 2002 ·Drug Metabolism and Disposition ·J. Van Gelder, S. Deferme, Lieve Naesens, Erik De Clercq, Guy Van den Mooter, Renaat Kinget, Patrick Augustijns	81
14	Safety assessment of selected cyclodextrins — effect on ciliary activity using a human cell suspension culture model exhibiting in vitro ciliogenesis 2000 ·International Journal of Pharmaceutics ·Remigius U. Agu, Mark Jorissen, Tom Willems, Guy Van den Mooter, Renaat Kinget, Norbert Verbeke, Patrick Augustijns	35
15	Effects of Pharmaceutical Compounds on Ciliary Beating in Human Nasal Epithelial Cells: A Comparative Study of Cell Culture Models 1999 ·Pharmaceutical Research ·Remigius U. Agu, Mark Jorissen, Tom Willems, Guy Van den Mooter, Renaat Kinget, Patrick Augustijns	29
16	Evaluation of the potential of ion pair formation to improve the oral absorption of two potent antiviral compounds, AMD3100 and PMPA 1999 ·International Journal of Pharmaceutics ·J. Van Gelder, Myriam Witvrouw, Christophe Pannecouque, (unknown), Gary Bridger, Lieve Naesens, Erik De Clercq, Pieter Annaert, (unknown), Guy Van den Mooter	25
17	Inhibition of Intestinal Metabolism of the Antiviral Ester Prodrug bis(POC)-PMPA by Nature-Identical Fruit Extracts as a Strategy to Enhance Its Oral Absorption: An In Vitro Study 1999 ·Pharmaceutical Research ·J. Van Gelder, Pieter Annaert, Lieve Naesens, Erik De Clercq, Guy Van den Mooter, Renaat Kinget, Patrick Augustijns	18
18	Development of inulin hydrogels as carriers for colonic drug targeting 1998 ·(unknown), Guy Van den Mooter, Patrick Augustijns, I. Vinckier, Paula Moldenaers, Renaat Kinget	2
19	In vitro degradation of acetyl and methyl inulins: implication for colon drug targeting 1998 ·Festo Damian, Guy Van den Mooter, Celest Samyn, Patrick Augustijns, Renaat Kinget	1
20	Inulin Hydrogels as Carriers for Colonic Drug Targeting: I. Synthesis and Characterization of Methacrylated Inulin and Hydrogel Formation 1997 ·Pharmaceutical Research ·Liesbeth Vervoort, Guy Van den Mooter, Patrick Augustijns, Roger Busson, Suzanne Toppet, Renaat Kinget	67

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact